The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.
Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-L...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/bc7785f27b4c46faa025687a64c79f6f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:bc7785f27b4c46faa025687a64c79f6f |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:bc7785f27b4c46faa025687a64c79f6f2021-11-18T07:15:09ZThe IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.1932-620310.1371/journal.pone.0039132https://doaj.org/article/bc7785f27b4c46faa025687a64c79f6f2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22723946/?tool=EBIhttps://doaj.org/toc/1932-6203Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-Like Receptor (TLR) pathway by MyD88-dependent agonists in bone marrow-derived macrophages (BMDMs) or RAW264.7 macrophages induces marked phosphorylation of LRRK2 at Ser910 and Ser935, the phosphorylation sites that regulate the binding of 14-3-3 to LRRK2. Phosphorylation of these residues is prevented by knock-out of MyD88 in BMDMs, but not the alternative TLR adaptor protein TRIF. Utilising both pharmacological inhibitors, including a new TAK1 inhibitor, NG25, and genetic models, we provide evidence that both the canonical (IKKα and IKKβ) and IKK-related (IKKε and TBK1) kinases mediate TLR agonist induced phosphorylation of LRRK2 in vivo. Moreover, all four IKK members directly phosphorylate LRRK2 at Ser910 and Ser935 in vitro. Consistent with previous work describing Ser910 and Ser935 as pharmacodynamic biomarkers of LRRK2 activity, we find that the TLR independent basal phosphorylation of LRRK2 at Ser910 and Ser935 is abolished following treatment of macrophages with LRRK2 kinase inhibitors. However, the increased phosphorylation of Ser910 and Ser935 induced by activation of the MyD88 pathway is insensitive to LRRK2 kinase inhibitors. Finally, employing LRRK2-deficient BMDMs, we present data indicating that LRRK2 does not play a major role in regulating the secretion of inflammatory cytokines induced by activation of the MyD88 pathway. Our findings provide the first direct link between LRRK2 and the IKKs that mediate many immune responses. Further work is required to uncover the physiological roles that phosphorylation of LRRK2 by IKKs play in controlling macrophage biology and to determine how phosphorylation of LRRK2 by IKKs impacts upon the use of Ser910 and Ser935 as pharmacodynamic biomarkers.Nicolas DzamkoFrancisco Inesta-VaqueraJiazhen ZhangChengsong XieHuaibin CaiSimon ArthurLi TanHwanguen ChoiNathanael GrayPhilip CohenPatrick PedrioliKristopher ClarkDario R AlessiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e39132 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Nicolas Dzamko Francisco Inesta-Vaquera Jiazhen Zhang Chengsong Xie Huaibin Cai Simon Arthur Li Tan Hwanguen Choi Nathanael Gray Philip Cohen Patrick Pedrioli Kristopher Clark Dario R Alessi The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| description |
Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-Like Receptor (TLR) pathway by MyD88-dependent agonists in bone marrow-derived macrophages (BMDMs) or RAW264.7 macrophages induces marked phosphorylation of LRRK2 at Ser910 and Ser935, the phosphorylation sites that regulate the binding of 14-3-3 to LRRK2. Phosphorylation of these residues is prevented by knock-out of MyD88 in BMDMs, but not the alternative TLR adaptor protein TRIF. Utilising both pharmacological inhibitors, including a new TAK1 inhibitor, NG25, and genetic models, we provide evidence that both the canonical (IKKα and IKKβ) and IKK-related (IKKε and TBK1) kinases mediate TLR agonist induced phosphorylation of LRRK2 in vivo. Moreover, all four IKK members directly phosphorylate LRRK2 at Ser910 and Ser935 in vitro. Consistent with previous work describing Ser910 and Ser935 as pharmacodynamic biomarkers of LRRK2 activity, we find that the TLR independent basal phosphorylation of LRRK2 at Ser910 and Ser935 is abolished following treatment of macrophages with LRRK2 kinase inhibitors. However, the increased phosphorylation of Ser910 and Ser935 induced by activation of the MyD88 pathway is insensitive to LRRK2 kinase inhibitors. Finally, employing LRRK2-deficient BMDMs, we present data indicating that LRRK2 does not play a major role in regulating the secretion of inflammatory cytokines induced by activation of the MyD88 pathway. Our findings provide the first direct link between LRRK2 and the IKKs that mediate many immune responses. Further work is required to uncover the physiological roles that phosphorylation of LRRK2 by IKKs play in controlling macrophage biology and to determine how phosphorylation of LRRK2 by IKKs impacts upon the use of Ser910 and Ser935 as pharmacodynamic biomarkers. |
| format |
article |
| author |
Nicolas Dzamko Francisco Inesta-Vaquera Jiazhen Zhang Chengsong Xie Huaibin Cai Simon Arthur Li Tan Hwanguen Choi Nathanael Gray Philip Cohen Patrick Pedrioli Kristopher Clark Dario R Alessi |
| author_facet |
Nicolas Dzamko Francisco Inesta-Vaquera Jiazhen Zhang Chengsong Xie Huaibin Cai Simon Arthur Li Tan Hwanguen Choi Nathanael Gray Philip Cohen Patrick Pedrioli Kristopher Clark Dario R Alessi |
| author_sort |
Nicolas Dzamko |
| title |
The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| title_short |
The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| title_full |
The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| title_fullStr |
The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| title_full_unstemmed |
The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. |
| title_sort |
ikappab kinase family phosphorylates the parkinson's disease kinase lrrk2 at ser935 and ser910 during toll-like receptor signaling. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/bc7785f27b4c46faa025687a64c79f6f |
| work_keys_str_mv |
AT nicolasdzamko theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT franciscoinestavaquera theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT jiazhenzhang theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT chengsongxie theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT huaibincai theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT simonarthur theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT litan theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT hwanguenchoi theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT nathanaelgray theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT philipcohen theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT patrickpedrioli theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT kristopherclark theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT darioralessi theikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT nicolasdzamko ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT franciscoinestavaquera ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT jiazhenzhang ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT chengsongxie ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT huaibincai ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT simonarthur ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT litan ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT hwanguenchoi ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT nathanaelgray ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT philipcohen ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT patrickpedrioli ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT kristopherclark ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling AT darioralessi ikappabkinasefamilyphosphorylatestheparkinsonsdiseasekinaselrrk2atser935andser910duringtolllikereceptorsignaling |
| _version_ |
1718423752675426304 |